Will PC et al. |
Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. |
1991 |
Agents Actions |
pmid:1793026
|
Vincent D et al. |
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig. |
1991 |
Agents Actions |
pmid:1793031
|
Desai S and Barton R |
Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. |
1990 |
Agents Actions |
pmid:2285021
|
Howat DW et al. |
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. |
1989 |
Agents Actions |
pmid:2801340
|
Appleby P and Bowen JG |
Cutaneous inflammatory disorders. |
1990 |
Agents Actions |
pmid:2117335
|
Lundgren JD et al. |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. |
1990 |
Agents Actions |
pmid:2117336
|
Doyle SA et al. |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. |
1990 |
Agents Actions |
pmid:2178317
|
Swingle KF and Reiter MJ |
Inhibition of Paf-acether-induced edema of the rat's paw. |
1986 |
Agents Actions |
pmid:2875631
|
Flower RJ |
Background and discovery of lipocortins. |
1986 |
Agents Actions |
pmid:2938452
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Montrucchio G et al. |
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. |
1987 |
Agents Actions |
pmid:3115072
|
Morley J |
Platelet activating factor and asthma. |
1986 |
Agents Actions |
pmid:3099555
|
Cahill M et al. |
Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. |
1988 |
Agents Actions |
pmid:3051930
|
Ramesha CS et al. |
Identification and quantitation of PAF from psoriatic scales. |
1987 |
Agents Actions |
pmid:3687590
|
Friedlander G et al. |
Renal effects of platelet-activating factor in the rat. |
1987 |
Agents Actions |
pmid:3687594
|
Touvay C et al. |
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. |
1986 |
Agents Actions |
pmid:3754380
|
Lauri D et al. |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. |
1986 |
Agents Actions |
pmid:3706054
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Perales J et al. |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. |
1992 |
Agents Actions |
pmid:1295374
|
Tran A et al. |
Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. |
1992 |
Agents Actions |
pmid:1414687
|
Northover AM |
In vitro effects of PAF on venous endothelial cell actin disposition. |
1992 |
Agents Actions |
pmid:1509977
|
Miyagawa H et al. |
The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils. |
1992 |
Agents Actions |
pmid:1456179
|
Lewis AJ et al. |
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. |
1984 |
Agents Actions |
pmid:6152379
|
Benveniste J |
Platelet-activating factor (PAF-acether): present status. |
1981 |
Agents Actions |
pmid:6176101
|
Northover AM and Northover BJ |
Lectin-induced increase in microvascular permeability to colloidal carbon in vitro may involve protein kinase C activation. |
1994 |
Agents Actions |
pmid:7942320
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Arnoux B et al. |
Release of PAF-acether from human blood monocytes. |
1982 |
Agents Actions |
pmid:7164946
|
Fouque F et al. |
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. |
1982 |
Agents Actions |
pmid:7164947
|
Lefort J et al. |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions. |
1982 |
Agents Actions |
pmid:7164948
|
Bonnet J et al. |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. |
1981 |
Agents Actions |
pmid:7340441
|
Denjean A et al. |
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. |
1981 |
Agents Actions |
pmid:7340444
|
Louis R et al. |
Potentiation of histamine release from human leucocytes by PAF. |
1994 |
Agents Actions |
pmid:7521570
|
Izzo AA et al. |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents. |
1994 |
Agents Actions |
pmid:7524288
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
de Bernardis E et al. |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema. |
1994 |
Agents Actions |
pmid:7847181
|
Kelefiotis D and Vakirtzi-Lemonias C |
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis. |
1993 |
Agents Actions |
pmid:8023738
|
Northover AM and Northover BJ |
Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. |
1993 |
Agents Actions |
pmid:8304240
|
Goldie RG et al. |
PAF receptors in guinea-pig and human lung. |
1990 |
Agents Actions Suppl. |
pmid:1964365
|
Codde JP et al. |
Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. |
1987 |
Agents Actions Suppl. |
pmid:3481207
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|